Japan Approves GSK's Antibody Treatment For COVID-19 Patients

The law number 5846 on Intellectual and Artistic Works is %100 applicable on all the material published on this news portal. Except as permitted under the policies of the related news agencies, no part of this website may be reproduced, stored in a retrieval system, communicated or transmitted in any form or by any means without prior written permission. For any other material published on this website; you may copy the content to individual third parties for their personal use, but only if you acknowledge the website as the source of the material and place a link.